Clinical Research Directory
Browse clinical research sites, groups, and studies.
Oxytocin in Multiparous Women
Sponsor: Rambam Health Care Campus
Summary
This is a randomized controlled trial investigating whether continuous oxytocin infusion in multiparous women shortens time to delivery, without altering maternal or neonatal outcomes, in augmented deliveries, compared to intermittent infusion.
Official title: Continuous Versus Intermittent Oxytocin Infusion for Induction of Labor in Multiparous Pregnant Women
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
166
Start Date
2024-04
Completion Date
2027-04
Last Updated
2024-04-18
Healthy Volunteers
Yes
Conditions
Interventions
Pitocin Injectable Product
The primary dose of oxytocin is 1.0 mU/min, with an incremental increase by 2.5 mU/min every 30 minutes, until 20.0 mU/min, tittered to a target of 3-5 contractions in a 10-minute period, or active labor (dilatation \> 6 cm).